You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Perilesional microglia

Showing 1 - 25 of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Salt Lake City

Recruiting
  • Secondary Progressive Multiple Sclerosis
  • +2 more
  • Ferumoxytol infusion
  • +2 more
  • Salt Lake City, Utah
    University of Utah Health Imaging and Neurosciences Center
Jun 22, 2022

Longitudinal Assessment of Iron Rims in MS Lesions

Not yet recruiting
  • Multiple Sclerosis
  • Blood sample provided
  • 7-T MRI scan
  • (no location specified)
Nov 5, 2021

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

Using IMC to Analyze the Impact of ICANS on Microglia

Recruiting
  • ICANS, Grade Unspecified
  • CAR T-Cell-Related Encephalopathy Syndrome
  • There will be no intervention as we will study patients that undergo autopsy after CAR T cell infusion.
  • Freiburg, Baden Württemberg, Germany
    Freiburg University Medical Center
Apr 12, 2023

Focal Laser Single Intravitreal Ranibizumab Retinal Artery

Completed
  • Retinal Artery Macroaneurysm
  • Dual focal laser and intravitreal Ranibizumab injection
  • Cairo, Egypt
    Kasr alainy faculty of medicine
Jan 29, 2023

Non-squamous NSCLC Trial in Guangzhou (FSRT combined with Bevacizumab)

Active, not recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • FSRT combined with Bevacizumab
  • Guangzhou, China
    Sun Yat-sen University
Nov 25, 2022

Measurement of QSM Signal (Quantitative Susceptibility Mapping)

Recruiting
  • White Matter Hyperintensity
  • Multiple Sclerosis
  • MRI
  • Paris, France
    Hhopital fondation adolphe de rothschild
Aug 11, 2022

Amyotrophic Lateral Sclerosis Trial in Finland, Sweden, United States (BLZ945)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • New Haven, Connecticut
  • +4 more
Aug 22, 2022

Schizophrenia Trial in London (Natalizumab, Placebo: normal saline)

Recruiting
  • Schizophrenia
  • London, United Kingdom
    Institute of Psychiatry, Psychology and Neuroscience, King's Col
Sep 27, 2022

Microglia Activation in Asthma

Recruiting
  • Asthma
  • Whole lung antigen challenge (WLAC)
  • [18F]FEPPA
  • Madison, Wisconsin
    University of Wisconsin Madison
Jul 14, 2022

Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)

Not yet recruiting
  • Alzheimer Disease
  • Placebo
  • +2 more
  • Paris, France
    Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022

Secondary-progressive Multiple Sclerosis Trial in Buffalo (Mayzent, Ocrevus)

Recruiting
  • Secondary-progressive Multiple Sclerosis
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Oct 10, 2022

Obesity Trial in New Haven (Intralipid Infusion)

Not yet recruiting
  • Obesity
  • Intralipid Infusion
  • New Haven, Connecticut
    Yale University
Oct 5, 2022

Cadasil Trial in Suita (Adrenomedullin)

Completed
  • Cadasil
  • Suita, Osaka, Japan
    National Cerebral and Cardiovascular Center
Oct 2, 2023

Alzheimer Trial in New Haven (LPS)

Recruiting
  • Alzheimer Disease
  • New Haven, Connecticut
    Alzheimer's Disease Research Unit
Feb 8, 2022

Selective PET Imaging of Astrocytes and Microglia in Alzheimer's

Recruiting
  • Alzheimer Disease
  • Healthy
  • Positron Emission Tomography (PET) using two PET tracer under IND
  • Houston, Texas
    Houston Methodist Research Institute
Jan 20, 2023

Tissue-resident Memory T Cells Expression in Melasma

Completed
  • Melasma
    • San Luis Potosí, Mexico
      Dermatology Department. Hospital Central "Dr. Ignacio Morones Pr
    Jan 15, 2023

    Microglia in the Pathogenesis of Progressive Multiple Sclerosis

    Active, not recruiting
    • Multiple Sclerosis
      • Turku, Finland Proper, Finland
        Turku PET Centre
      Oct 12, 2022

      Critical Asymptomatic Carotid Artery Disease, Non-Critical Asymptomatic Carotid Artery Disease Trial in Birmingham

      Recruiting
      • Critical Asymptomatic Carotid Artery Disease
      • Non-Critical Asymptomatic Carotid Artery Disease
      • Birmingham, Alabama
        UAB
      Dec 13, 2022

      SARS-CoV-2 Neurotropic Capacity in Modestly and Critically Ill

      Active, not recruiting
      • COVID-19 Disease
      • Data collection from lumbar puncture
      • +3 more
      • Basel, Switzerland
        Neurosurgery, University Hospital Basel
      Nov 1, 2021

      Parkinson Disease Trial in Birmingham (DPA-714-PET/MRI)

      Recruiting
      • Parkinson Disease
      • Birmingham, Alabama
        UAB Advanced Imaging Facility
      Mar 29, 2022

      Fibromyalgia, Chronic Fatigue Syndrome, Multiple Sclerosis Trial in Birmingham (DPA-714 PET/MRI)

      Recruiting
      • Fibromyalgia
      • +3 more
      • DPA-714 PET/MRI
      • Birmingham, Alabama
        University of Alabama at Birmingham Medical Center
      Dec 3, 2021

      Alzheimer Trial in Boston (Transcranial Alternating Current Stimulation (tACS))

      Completed
      Has Results
      • Alzheimer Disease
      • Transcranial Alternating Current Stimulation (tACS)
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Feb 2, 2022

      Alzheimer Trial in New York (11C-ER176, 18F-florbetaben)

      Recruiting
      • Alzheimer Disease
      • New York, New York
        Columbia University Irving Medical Center
      Jan 10, 2022

      REM Sleep Behavior Disorder Trial in Camperdown, Oxford (PXS-4728 (A), Matching Placebo (B))

      Not yet recruiting
      • REM Sleep Behavior Disorder
      • PXS-4728 (A)
      • Matching Placebo (B)
      • Camperdown, Sydney, Australia
      • +1 more
      Jun 6, 2023